News
Researchers develop new protein mapping tool
2+ hour, 29+ min ago (153+ words) Millennium Post Researchers develop new protein mapping tool New Delhi: Researchers at the Jawaharlal Nehru Centre for Advanced Scientific Research (JNCASR), Bengaluru, have developed a new imaging platform called Cleavable Light-Erased Antibody Reporter (CLEAR) that allows scientists to visualise multiple…...
Aphios Corporation Announces Notice of Allowance for Novel Bryoid Composition Patent Targeting Alzheimer's Disease, Multiple Sclerosis, HIV Latency and Cancer
3+ hour, 11+ min ago (163+ words) The allowed claims relate to a novel Bryoid composition designated B14 B, including methods of isolation, purification, and manufacture. The USPTO determined that the claimed Bryoid composition demonstrated novelty and non-obviousness over prior bryostatin-related art. The patent application is part of…...
Transfer learning-assisted discovery of novel gp130 inhibitors for colorectal cancer therapy
4+ hour, 31+ min ago (458+ words) An artificial intelligence'driven transfer learning strategy enabled the discovery of a novel indolopyridine-based small molecule (Compound 8a) that directly targets gp130, potently suppresses the JAK2/STAT3 signaling pathway, and effectively inhibits colorectal cancer growth in vitro and in vivo, offering a promising lead and…...
Biocytogen Launches AI-Powered Ren Super" Platform and Industry-First Fully Automated Antibody Discovery Infrastructure
5+ hour, 33+ min ago (446+ words) Beirut (AFP) | 26/05/2026 - 14: 25: 08 | Lebanon says Israeli strike on Monday killed at least 11 people Dubai (AFP) | 26/05/2026 - 14: 22: 20 | Explosion damages tanker off Oman: marine monitor Tehran (AFP) | 26/05/2026 - 14: 15: 10 | Iran judiciary suspends presidential body after it ordered internet restored Yerevan (AFP) | 26/05/2026 - 14: 01: 06 | Rubio opens talks in Armenia…...
New scaffold system produces larger human gut organoids
9+ hour, 30+ min ago (241+ words) Scientists in the US and France have created 3 D-printed scaffold trays that produce larger functional human gut organoids capable of developing their own nerve cells. This improved technology could help accelerate production of human mini-organ tissues that are large enough…...
Decoy Therapeutics Appoints MIT Chemist Brad Pentelute to Lead Scientific Advisory Board
8+ hour, 29+ min ago (430+ words) Decoy Therapeutics has named MIT chemistry professor and company co-founder Brad Pentelute as chair of its scientific advisory board, strengthening the biotechnology company's scientific leadership as it advances a new class of broad-spectrum antiviral therapies. The appointment comes as drug…...
Discovery of a KLHL41 Ligand for Muscle Specific Protein Degradation - Nature Communications
18+ hour, 4+ min ago (1728+ words) Although KBD-1 and KBD-2 show their potential for muscle cell-specific TPD, their degradation activity remains in the micromolar range in RH30 cells, which limits their potential clinical applications (Fig. 3f, g). This potency is significantly less effective compared to that of clinically advanced…...
Scientists Used Toy Robot Parts To Build A $5 Fake Drug Detector - AOL
2+ week, 3+ day ago (464+ words) Scientists Used Toy Robot Parts To Build A $5 Fake Drug Detector AOL. com Counterfeit medications are a growing issue worldwide that has deadly consequences. In the U. S. , illegal online pharmacies sell cheap, unprescribed medications sometimes laced with fentanyl. The situation is…...
Century Health Announces $5 M Seed Round as AI-Powered Platform Achieves 97% Accuracy in Clinical Data Abstraction
15+ hour, 45+ min ago (256+ words) Century Health was founded to reimagine how clinical data is used to benefit patients. The company's Century Health Abstraction & Retrieval Model (CHARM) is a tailored, AI-powered platform that automates the curation and enrichment of fragmented clinical data, creating high-quality real-world…...
Biomunex Announces Strategic Artificial Intelligence Collaborations to Further Accelerate the Discov
7+ hour, 2+ min ago (287+ words) These two collaborations reflect Biomunex's commitment to combining the scientific strength of its proprietary platform technologies with the capabilities offered by AI in several R&D axes, particularly to optimize target selection, shorten discovery timelines, and increase the probability of…...